July 27 (Reuters) - Emerald Health Therapeutics Inc EMH.V :
* EMERALD HEALTH PHARMACEUTICALS BEGINS ENROLLMENT IN PHASE 2A STUDY OF EHP-101 FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
July 27 (Reuters) - Emerald Health Therapeutics Inc EMH.V :
* EMERALD HEALTH PHARMACEUTICALS BEGINS ENROLLMENT IN PHASE 2A STUDY OF EHP-101 FOR THE TREATMENT OF SYSTEMIC SCLEROSIS